Soccer legend Abby Wambach said colon cancer screening at 35 likely saved her life [Business Insider]
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: Business Insider
Chris Graythen/Getty Images This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Have an account? Log in Olympic gold medalist and soccer star Abby Wambach said a colonoscopy at 35 likely saved her life. The test found polyps that, with her family history of cancer, put her at high risk. Colon cancer is now the leading cause of cancer-related deaths under 50. Early screening is crucial. AI-generated summary Summaries are generated by an AI model trained on Business Insider's articles. AI may make mistakes or provide inaccurate/incomplete information. We're unable to load that answer right now. Please try again. What are early signs of colon cancer? How does family history affect cancer risk? How has cancer screening age changed? Why is early cancer screening important? What is Cologuard and how does it work? At the height of her soccer career, Abby Wambach felt invincible. A FIFA world champion, tw
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- Columbia Cornerstone Growth Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- Exact Sciences (EXAS) had its "neutral" rating reaffirmed by BTIG Research.MarketBeat
- Abbott closes $23 billion deal to buy Madison-based Exact Sciences [Yahoo! Finance]Yahoo! Finance
- Abbott completes acquisition of Exact Sciences [Yahoo! Finance]Yahoo! Finance
- How Walgreens' Pharmacy-Led Cologuard Expansion At Exact Sciences (EXAS) Has Changed Its Investment Story [Yahoo! Finance]Yahoo! Finance
EXAS
Earnings
- 2/13/26 - Miss
EXAS
Sec Filings
- 3/23/26 - Form POSASR
- 3/23/26 - Form S-8
- 3/23/26 - Form S-8
- EXAS's page on the SEC website